Noetic Fund

noeticfund.com

VCMatch tracks Noetic Fund as an investor focused on Biotech, Digital Health, and Medtech companies, Pre-Seed and Seed rounds, Global, US, and Canada markets, and $6.95m to $22m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$6.95m to $22m

Stages

Pre-Seed, Seed, Series A

Focus Areas

Biotech, Digital Health, Medtech

Geography

Global, US, and Canada

Investment Thesis

Noetic Fund invests in early-stage technologies addressing mental health and wellbeing with a diversified, multi-modal strategy. Their approach emphasizes scientific advancement and human flourishing, seeking emerging therapies and modalities committed to optimizing the human experience. The firm focuses on treatments that target root causes of illness while emphasizing early intervention and prevention.

Is Noetic Fund right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Noetic Fund is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Biotech, Digital Health, Medtech, and Healthtech, especially across Global, US, and Canada, with public check-size signals around $6.95m to $22m.

Focus statement

CNS-targeted therapeutics and related sustainable solutions for mental health and physical wellbeing. Noetic invests across novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions with a global outlook.

Value Add

Deep expertise in psychedelic-assisted therapies and novel drug discovery - team includes founder/CSO of portfolio company and scientists with peer-reviewed publications
Emphasis on 'root cause' treatment rather than symptom management
Commitment to sustainability, innovation, safety and accessibility in developed solutions
Strong scientific credibility through team credentials (Ph.D. in Biology from Max Planck Society, pharmaceutical sciences expertise, etc.)
Active intellectual engagement through 'Noetic Sessions of Intellectual Discovery' featuring leading researchers and thought leaders
Focus on evidence-backed solutions rather than speculative approaches